EyePoint Pharmaceuticals (EYPT) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

EyePoint Pharmaceuticals (EYPT) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 25, 2024 (09:51)

Sector: Healthcare

The share price of EyePoint Pharmaceuticals, Inc. (EYPT) now

Latest session on the 24th of April for
EyePoint Pharmaceuticals, Inc. is negative
Trading Volume: 1178938
Open: 17.57 /  High: 17.85 /  Low: 16.22
What analysts predict: $43.67
52-week High/Low: $30.99 / $5.67

50/200 Day Moving Average: $23.86 / $15.99

This figure corresponds to the Average Price over the previous 50/200 days. For EyePoint Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For EyePoint Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in EyePoint Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the EyePoint Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one EyePoint Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in EyePoint Pharmaceuticals stock? When should I record a loss on EyePoint Pharmaceuticals stock? What are analysts' forecasts for EyePoint Pharmaceuticals stock? What is the future of EyePoint Pharmaceuticals stock? We forecast EyePoint Pharmaceuticals stock performance using neural networks based on historical data on EyePoint Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

EyePoint Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for EyePoint Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of EyePoint Pharmaceuticals stock

The chart below shows the historical price of EyePoint Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EyePoint Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 27 16.91 16.49 17.44 5.74
Apr 28 17.20 16.88 17.82 5.61
Apr 29 16.42 16.11 16.85 4.59
Apr 30 16.04 15.52 16.39 5.63
May 01 16.13 15.74 16.68 6.00
May 02 16.33 16.15 16.69 3.34
May 03 16.13 15.79 16.66 5.52
May 04 15.98 15.54 16.20 4.27
May 05 15.70 15.33 16.06 4.76
May 06 15.85 15.51 16.37 5.52
May 07 16.03 15.86 16.46 3.79
May 08 15.91 15.72 16.12 2.53
May 09 15.98 15.45 16.34 5.74
May 10 16.35 16.13 16.70 3.55
May 11 16.61 16.03 17.21 7.36
May 12 16.22 15.58 16.67 6.98
May 13 16.54 16.33 16.92 3.59
May 14 16.38 15.87 16.83 6.09
May 15 16.32 15.72 16.61 5.66
May 16 16.59 16.34 17.17 5.08
May 17 16.98 16.46 17.42 5.83
May 18 16.66 16.25 17.26 6.26
May 19 16.62 16.36 17.00 3.96
May 20 16.95 16.38 17.61 7.50
May 21 16.81 16.64 17.05 2.47
May 22 17.49 16.79 17.75 5.73
May 23 16.94 16.45 17.13 4.12
May 24 16.74 16.12 17.37 7.79
May 25 16.68 16.15 16.98 5.11
May 26 16.27 15.62 16.87 8.02

EyePoint Pharmaceuticals Daily Price Targets


EyePoint Pharmaceuticals Stock Forecast 04-27-2024.

Forecast target price for 04-27-2024: $16.91.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.429%.
Pessimistic target level: 16.49
Optimistic target level: 17.44

EyePoint Pharmaceuticals Stock Forecast 04-28-2024.

Forecast target price for 04-28-2024: $17.20.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.309%.
Pessimistic target level: 16.88
Optimistic target level: 17.82

EyePoint Pharmaceuticals Stock Forecast 04-29-2024.

Forecast target price for 04-29-2024: $16.42.
Negative dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 4.386%.
Pessimistic target level: 16.11
Optimistic target level: 16.85

EyePoint Pharmaceuticals Stock Forecast 04-30-2024.

Forecast target price for 04-30-2024: $16.04.
Negative dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.333%.
Pessimistic target level: 15.52
Optimistic target level: 16.39

EyePoint Pharmaceuticals Stock Forecast 05-01-2024.

Forecast target price for 05-01-2024: $16.13.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.658%.
Pessimistic target level: 15.74
Optimistic target level: 16.68

EyePoint Pharmaceuticals Stock Forecast 05-02-2024.

Forecast target price for 05-02-2024: $16.33.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 3.229%.
Pessimistic target level: 16.15
Optimistic target level: 16.69

EYPT (EYPT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 18.01 15.86 19.21 17.46
Jun. 17.60 15.03 18.64 19.38
Jul. 17.74 16.93 20.16 16.04
Aug. 15.28 13.71 16.81 18.47
Sep. 14.84 13.85 15.52 10.72
Oct. 16.25 15.14 16.96 10.74
Nov. 18.87 16.54 21.60 23.41
Dec. 19.20 17.92 21.68 17.33

EyePoint Pharmaceuticals forecast for this year


EyePoint Pharmaceuticals Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $18.0128. Pessimistic: $15.86. Optimistic: $19.21


EyePoint Pharmaceuticals Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $17.6021. Pessimistic: $15.03. Optimistic: $18.64


EyePoint Pharmaceuticals Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $17.7358. Pessimistic: $16.93. Optimistic: $20.16


EyePoint Pharmaceuticals Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $15.2759. Pessimistic: $13.71. Optimistic: $16.81


EyePoint Pharmaceuticals Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $14.8405. Pessimistic: $13.85. Optimistic: $15.52


EyePoint Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $16.2504. Pessimistic: $15.14. Optimistic: $16.96


EyePoint Pharmaceuticals Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $18.8748. Pessimistic: $16.54. Optimistic: $21.60


EyePoint Pharmaceuticals Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $19.1976. Pessimistic: $17.92. Optimistic: $21.68



EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 20.62 18.66 21.76 14.23
Feb 17.60 16.06 18.44 12.88
Mar 18.24 17.16 18.97 9.50
Apr 19.49 17.93 21.26 15.67
May 21.93 18.93 23.68 20.06
Jun 23.51 20.65 25.66 19.50
Jul 22.04 19.40 24.89 22.04
Aug 24.47 23.07 26.89 14.18
Sep 23.45 22.55 24.83 9.15
Oct 25.67 23.72 29.48 19.53
Nov 26.79 24.25 29.90 18.90
Dec 23.13 21.37 25.46 16.05

EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 19.48 17.67 21.04 16.01
Feb 17.96 16.84 20.52 17.96
Mar 14.76 14.08 16.07 12.38
Apr 16.55 15.76 17.74 11.16
May 19.51 17.80 22.17 19.72
Jun 19.39 18.55 21.61 14.16
Jul 18.92 16.62 20.93 20.61
Aug 19.49 17.31 20.56 15.85
Sep 16.64 14.77 17.75 16.75
Oct 14.58 12.76 15.83 19.43
Nov 13.67 13.05 14.34 9.05
Dec 14.94 14.12 16.56 14.74

EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 14.52 13.14 15.67 16.19
Feb 13.88 11.90 15.33 22.36
Mar 13.35 11.58 15.03 22.96
Apr 12.95 11.74 13.83 15.12
May 13.15 12.45 14.67 15.15
Jun 14.37 13.28 15.46 14.13
Jul 16.69 15.64 18.28 14.40
Aug 15.52 14.90 16.37 9.00
Sep 16.40 15.59 18.58 16.10
Oct 17.59 16.62 18.85 11.87
Nov 18.75 16.30 19.54 16.60
Dec 21.18 19.45 22.55 13.74

EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 23.47 21.06 25.97 18.89
Feb 26.59 25.38 29.57 14.18
Mar 25.23 21.78 27.53 20.89
Apr 28.63 26.40 32.06 17.65
May 30.21 25.62 32.73 21.74
Jun 31.53 26.98 33.69 19.92
Jul 36.74 31.65 40.44 21.75
Aug 39.67 35.38 42.09 15.94
Sep 38.47 35.18 40.95 14.10
Oct 38.10 34.41 42.01 18.09
Nov 40.06 36.94 45.46 18.75
Dec 41.12 37.84 43.39 12.79

EyePoint Pharmaceuticals information and performance

EyePoint Pharmaceuticals Address

480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US

Market Capitalization: 879 514 000 $

Market capitalization of the EyePoint Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYPT shares in the company outstanding by the market price of one share.

EBITDA: -73 402 800 $

EBITDA of EyePoint Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.332
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 17.23

Enterprise Value (EV) /Revenue

EV To EBITDA: -11.49

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49830800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

EyePoint Pharmaceuticals (EYPT) stock dividend

EyePoint Pharmaceuticals last paid dividends on 01/01/1970. The next scheduled payment will be on 12/09/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.